Want to see JP:3353 full AI Analyst Report?
3353 Stock Chart & Stats
¥2930.00
¥4.00(0.19%)
At close: 4:00 PM EST
¥2930.00
¥4.00(0.19%)
Day’s Range― - ―
52-Week Range¥2,590.00 - ¥3,355.00
Previous CloseN/A
Volume1.00K
Average Volume (3M)5.09K
Market Cap
¥9.82B
Enterprise Value¥14.39B
Total Cash (Recent Filing)¥6.12B
Total Debt (Recent Filing)¥10.36B
Price to Earnings (P/E)7.3
Beta0.46
Next Earnings
Oct 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.22%
Share Statistics
EPS (TTM)338.74
Shares Outstanding3,770,000
10 Day Avg. Volume10,430
30 Day Avg. Volume5,086
Financial Highlights & Ratios
PEG Ratio0.73
Price to Book (P/B)0.73
Price to Sales (P/S)0.21
P/FCF Ratio52.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue MomentumRevenue acceleration over recent years signals expanding prescription volume or successful store/network initiatives. Sustained top-line growth supports scale, improves cost absorption and provides a steadier earnings base under Japan's reimbursed pharmacy model, aiding medium-term durability.
Improving LeverageMaterial reduction in leverage meaningfully lowers financial risk and increases strategic optionality. A healthier balance sheet improves resilience to reimbursement or demand shocks, enables selective reinvestment or M&A, and reduces interest burden over the medium term.
Predictable Pharmacy Revenue BaseCore business relies on reimbursed dispensing fees and prescription volumes, creating recurring, contract-like cash flows tied to the national insurance system. That structural demand and payment framework supports predictable revenues and defensive characteristics over months to years.
Bears Say
Weak Cash ConversionOperating cash flow is very low relative to reported earnings and free cash flow covers a small share of net income, indicating working-capital swings or non-cash items. This undermines the durability of reported profits and limits internally funded investment and dividends.
Low And Soft MarginsModest gross and net margins and recent EBITDA margin compression point to margin pressure from costs or product mix. Persistently thin profitability constrains cash generation, reduces buffer for shocks, and limits reinvestment capacity over the medium term.
Moderate Returns On EquityMid-single-digit ROE implies limited capital efficiency versus higher-return peers. Modest ROE makes it harder to self-fund accelerated growth or generate strong shareholder returns without operational improvements or higher-margin initiatives.
3353 FAQ
What was Medical Ikkou Group Co., Ltd.’s price range in the past 12 months?
Medical Ikkou Group Co., Ltd. lowest stock price was ¥2590.00 and its highest was ¥3355.00 in the past 12 months.
What is Medical Ikkou Group Co., Ltd.’s market cap?
Medical Ikkou Group Co., Ltd.’s market cap is ¥9.82B.
When is Medical Ikkou Group Co., Ltd.’s upcoming earnings report date?
Medical Ikkou Group Co., Ltd.’s upcoming earnings report date is Oct 05, 2026 which is in 61 days.
How were Medical Ikkou Group Co., Ltd.’s earnings last quarter?
Medical Ikkou Group Co., Ltd. released its earnings results on Jul 10, 2026. The company reported ¥169.33 earnings per share for the quarter, beating the consensus estimate of N/A by ¥169.33.
Is Medical Ikkou Group Co., Ltd. overvalued?
According to Wall Street analysts Medical Ikkou Group Co., Ltd.’s price is currently Overvalued.
Does Medical Ikkou Group Co., Ltd. pay dividends?
Medical Ikkou Group Co., Ltd. pays a Semiannually dividend of ¥60 which represents an annual dividend yield of 4.22%. See more information on Medical Ikkou Group Co., Ltd. dividends here
What is Medical Ikkou Group Co., Ltd.’s EPS estimate?
Medical Ikkou Group Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medical Ikkou Group Co., Ltd. have?
Medical Ikkou Group Co., Ltd. has 3,770,000 shares outstanding.
What happened to Medical Ikkou Group Co., Ltd.’s price movement after its last earnings report?
Medical Ikkou Group Co., Ltd. reported an EPS of ¥169.33 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.86%.
Which hedge fund is a major shareholder of Medical Ikkou Group Co., Ltd.?
Currently, no hedge funds are holding shares in JP:3353
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medical Ikkou Group Co., Ltd.
Medical Ikkou Group Co., Ltd. (3353) is a Japan-based healthcare company that operates primarily in the pharmaceutical and medical services domain. The group’s core activities include the operation of dispensing (prescription) pharmacies and related healthcare support services. null
Technical Analysis
LIKE, Inc.
―
Tamagawa Holdings Co., Ltd.
―
halmek holdings Co.,Ltd.
―
I. A Group Corporation
―
People, Dreams & Technologies Group Co., Ltd.
―